Shenzhen, China

Miaomiao Zhang

This inventor holds 5 USPTO granted patents and 2 published patent applications and 4 EPO patents. Top assignees: Shenzhen Rhegen Biotechnology Co., Ltd., Huawei Technologies Co., Limited. Active years: 2017-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Miaomiao Zhang. Retrieved from https://idiyas.com/inventor/miaomiao-zhang

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 5 

% Patents Active = 80.0

 

Average Co-Inventor Count = 2.4

ph-index = 1

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 2017-2025

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Miaomiao Zhang: Innovator in RNA Technology

Introduction

Miaomiao Zhang is a prominent inventor based in Shenzhen, China. She has made significant contributions to the field of RNA technology, holding 5 patents that focus on innovative methods for RNA synthesis and modification. Her work is paving the way for advancements in mRNA drug delivery systems.

Latest Patents

Miaomiao Zhang's latest patents include a method for large-scale synthesis of long-chain RNA and a method for site-specific modification of long-chain RNA. The large-scale synthesis method involves designing short RNA fragments and splint DNA fragments, followed by ligation, capping, and removal of splint DNA fragments. This process allows for the high-throughput production of long-chain RNA with a low mutation rate. Additionally, her method for site-specific modification enables precise chemical modifications of the RNA, enhancing its functionality in drug delivery applications.

Another notable patent is the development of an mRNA targeting molecule comprising an N-acetylgalactosamine binding polypeptide. This invention outlines a preparation method that involves creating a plasmid vector, transcribing it to obtain mRNA, and forming a complex that enhances the efficacy of mRNA drug molecules. This innovative approach aims to improve the precision of mRNA drug delivery.

Career Highlights

Miaomiao Zhang has worked with notable companies such as Shenzhen Rhegen Biotechnology Co., Ltd. and Huawei Technologies Co., Limited. Her experience in these organizations has contributed to her expertise in biotechnology and RNA research.

Collaborations

Miaomiao has collaborated with esteemed colleagues, including Yong Hu and Guangjian Wang, to further her research and development efforts in RNA technology.

Conclusion

Miaomiao Zhang is a trailblazer in the field of RNA technology, with her innovative patents and contributions significantly impacting the future of mRNA drug delivery systems. Her work exemplifies the potential of RNA-based therapies in modern medicine.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…